C-Reactive Protein Testing Global Market Report 2026
상품코드:1942633
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
C 반응성 단백질 검사 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 35억 2,000만 달러에서 2026년에는 37억 달러로, CAGR 5.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장세는 염증성 질환의 유병률 증가, 임상 진단에서의 CRP 검사 활용 확대, 병원 검사실 인프라 확충, 조기 질환 발견에 대한 인식 개선, 표준화된 검사 키트의 보급 등이 주요 요인으로 꼽히고 있습니다.
C 반응성 단백질 검사 시장 규모는 향후 수년간 꾸준한 성장이 전망됩니다. 2030년에는 44억 8,000만 달러에 달하며, CAGR은 4.9%에 달할 전망입니다. 예측 기간의 성장 요인으로는 POC(Point-Of-Care) 염증 검사 수요 증가, 자동화 진단 플랫폼의 통합 확대, 예방 의료 스크리닝 확대, 고처리량 검사 시스템 도입 확대, 맞춤형 의료 진단에 대한 집중 강화 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 고감도 CRP 측정법 채택 확대, 자동 면역측정 시스템 사용 증가, 신속한 염증 진단에 대한 수요 증가, 심혈관 위험 평가에서 CRP 검사 확대, 검사실 워크플로우 자동화에 대한 집중 강화 등을 들 수 있습니다.
심혈관 질환(CVD) 사례 증가는 C 반응성 단백질 검사 시장의 성장을 촉진할 것으로 예측됩니다. 심혈관 질환에는 혈관 질환, 구조적 문제, 혈전 등의 심장 질환이 포함됩니다. CVD의 정확한 원인은 완전히 밝혀지지 않았지만, 발병 위험을 높이는 몇 가지 요인이 존재합니다. 중요한 요인 중 하나는 부적절한 식습관, 운동 부족, 흡연, 음주와 같은 행동 위험입니다. 이는 동맥내 지방 침착(동맥경화)을 촉진하고 혈전 위험을 높입니다. 이러한 행동 위험은 고혈압, 고혈당, 고지혈증, 체중 증가, 비만의 요인이 됩니다. 심혈관 질환 환자가 증가함에 따라 콜레스테롤 검사와 마찬가지로 심혈관 질환의 진단 및 발병 예측을 위한 C 반응성 단백질 검사에 대한 수요가 증가하고 있습니다. 예를 들어 2023년 12월 건강지표평가연구소가 발표한 보고서에 따르면 2022년 심혈관 질환으로 인한 전 세계 사망자 수는 1,980만 명에 달하고, 허혈성 심장질환 사망률은 10만 명당 108.8명입니다. 심혈관 질환과 관련된 장애 조정 수명(DALY)의 주요 요인은 수축기 고혈압이며, 식습관 위험과 대기오염이 이 세계적인 문제를 악화시키는 중요한 행동적, 환경적 요인으로 부상하고 있습니다.
C 반응성 단백질(CRP) 검사 시장의 주요 기업은 보다 정확하고 신속한 저농도 CRP 검출을 가능하게 하는 고감도 자동 면역측정법 등 기술 혁신에 주력하고 있으며, 이를 통해 조기 심혈관 위험 평가 및 실시간 염증 모니터링을 지원하고 있습니다. 고감도 자동 면역측정법은 개선된 면역 탁도법 또는 네페로메트리 기술을 사용하여 표준 측정법보다 훨씬 낮은 CRP 농도를 감지하여 조기 개입 및 예후 평가를 개선할 수 있습니다. 2024년 1월, 독일에 본사를 둔 체외진단 전문기업 지멘스 헬스인어스(Siemens Healthineers)는 Atellica CH 분석기용 'Atellica CH 고감도 C 반응성 단백질 2(hCRP2) 분석기'를 발표했습니다. 본 시스템은 2유형의 즉시 사용 가능한 시약 팩을 사용하여 CRP에 의한 입자 응집에 의한 광 산란을 측정합니다. 혈청 또는 혈장 검체에 대응하는 신속하고 정량적인 결과를 제공하여 적시에 임상적 판단을 지원합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.
The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.
Tariffs are influencing the c-reactive protein testing market by increasing costs of imported reagents, assay kits, analyzers, and diagnostic instrumentation used across elisa, clia, and immunoturbidimetric platforms. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported testing systems, while Asia-Pacific faces cost pressures on reagent supply chains. These tariffs are raising operational costs and impacting test pricing. At the same time, they are encouraging local reagent manufacturing, regional analyzer assembly, and domestic diagnostic technology development.
The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with a c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The c-reactive protein testing market size has grown strongly in recent years. It will grow from $3.52 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing prevalence of inflammatory diseases, rising use of crp testing in clinical diagnostics, expansion of hospital laboratory infrastructure, growing awareness of early disease detection, availability of standardized assay kits.
The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for point-of-care inflammatory testing, rising integration of automated diagnostics platforms, expansion of preventive healthcare screening, growing adoption of high-throughput laboratory systems, increasing focus on personalized medicine diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity crp assays, rising use of automated immunoassay systems, growing demand for rapid inflammation diagnostics, expansion of crp testing in cardiovascular risk assessment, enhanced focus on laboratory workflow automation.
The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.
Major players in the C-Reactive Protein testing market are focusing on technological advancements such as high-sensitivity automated immunoassays for more accurate, rapid, and low-level CRP detection, supporting early cardiovascular risk assessment and real-time inflammation monitoring. High-sensitivity automated immunoassays use refined immunoturbidimetric or nephelometric techniques to detect CRP levels far below standard assays, enabling earlier intervention and improved prognostic evaluation. In January 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, launched the Atellica CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay for its Atellica CH Analyzer. The system uses two ready-to-use reagent packs and measures light scattering caused by CRP-induced particle aggregation, providing rapid, quantitative results compatible with serum or plasma samples for timely clinical decision-making.
In July 2024, Roche, a Switzerland-based diagnostics company, acquired LumiraDx's point-of-care platform for an undisclosed amount. Through this acquisition, Roche seeks to enhance its CRP testing capabilities by incorporating LumiraDx's rapid, quantitative CRP assay into its diagnostics portfolio and expanding access to point-of-care immunoassays. LumiraDx is a UK-based company that offers a multi-assay point-of-care platform, including a microfluidic immunoassay for quantitative C-Reactive Protein testing.
Major companies operating in the c-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation
North America was the largest region in the c-reactive protein testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
C-Reactive Protein Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of High-Sensitivity Crp Assays
4.2.2 Rising Use Of Automated Immunoassay Systems
4.2.3 Growing Demand For Rapid Inflammation Diagnostics
4.2.4 Expansion Of Crp Testing In Cardiovascular Risk Assessment
4.2.5 Enhanced Focus On Laboratory Workflow Automation
5. C-Reactive Protein Testing Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Diagnostic Laboratories
5.3 Clinics
5.4 Specialty Care Centers
5.5 Research Laboratories
6. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global C-Reactive Protein Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global C-Reactive Protein Testing Market Size, Comparisons And Growth Rate Analysis
7.3. Global C-Reactive Protein Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global C-Reactive Protein Testing Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. C-Reactive Protein Testing Market Segmentation
9.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinics, Hospitals, Diagnostic Laboratories
9.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Direct ELISA, Indirect ELISA, Sandwich ELISA
9.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Luminometer-Based CLIA, Automated CLIA Systems
9.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. C-Reactive Protein Testing Market Regional And Country Analysis
10.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific C-Reactive Protein Testing Market
11.1. Asia-Pacific C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China C-Reactive Protein Testing Market
12.1. China C-Reactive Protein Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India C-Reactive Protein Testing Market
13.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan C-Reactive Protein Testing Market
14.1. Japan C-Reactive Protein Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia C-Reactive Protein Testing Market
15.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia C-Reactive Protein Testing Market
16.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea C-Reactive Protein Testing Market
17.1. South Korea C-Reactive Protein Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan C-Reactive Protein Testing Market
18.1. Taiwan C-Reactive Protein Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia C-Reactive Protein Testing Market
19.1. South East Asia C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe C-Reactive Protein Testing Market
20.1. Western Europe C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK C-Reactive Protein Testing Market
21.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany C-Reactive Protein Testing Market
22.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France C-Reactive Protein Testing Market
23.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy C-Reactive Protein Testing Market
24.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain C-Reactive Protein Testing Market
25.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe C-Reactive Protein Testing Market
26.1. Eastern Europe C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia C-Reactive Protein Testing Market
27.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America C-Reactive Protein Testing Market
28.1. North America C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA C-Reactive Protein Testing Market
29.1. USA C-Reactive Protein Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada C-Reactive Protein Testing Market
30.1. Canada C-Reactive Protein Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America C-Reactive Protein Testing Market
31.1. South America C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil C-Reactive Protein Testing Market
32.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East C-Reactive Protein Testing Market
33.1. Middle East C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa C-Reactive Protein Testing Market
34.1. Africa C-Reactive Protein Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. C-Reactive Protein Testing Market Regulatory and Investment Landscape
36. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles
36.1. C-Reactive Protein Testing Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. C-Reactive Protein Testing Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. C-Reactive Protein Testing Market Company Profiles
36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
37. C-Reactive Protein Testing Market Other Major And Innovative Companies
